Browse > Article
http://dx.doi.org/10.5762/KAIS.2019.20.3.188

A Rare Case of Acquired Arteriovenous Malformation in Transarterial Chemoembolization for Hepatocellular Carcinoma  

Moon, Sung-Nam (Department of Radiology, Wonkwang University Hospital)
Seo, Sang-Hyun (Department of Radiology, Wonkwang University Hospital)
Publication Information
Journal of the Korea Academia-Industrial cooperation Society / v.20, no.3, 2019 , pp. 188-193 More about this Journal
Abstract
Transarterial chemoembolization (TACE) is a commonly used and rapidly evolving non-invasive treatment for hepatocellular carcinoma (HCC). It is important that understanding individual anatomical variants and planning for tumor-feeding artery access to acquire adequate treatment effectiveness. In this study, we will report acquired arteriovenous malformation which interferes with TACE for HCC. A 72-year-old man with persistent abdominal pain for 2 days visited our hospital. The patient was chronic hepatitis B carrier and had a history of HCC treated with conventional TACE 10 years ago. Hypervascular nodular HCC in the liver segment 8 and aberrant right hepatic artery from the superior mesenteric artery were detected on computed tomography (CT). When first TACE was performed, the tumor-feeding artery originating from the left hepatic artery was found and embolized. There was no tumor-feeding artery from the right hepatic artery but arteriovenous malformation was found. After a month, follow up CT showed necrotic lesion and residual HCC and we performed secondary TACE. On secondary TACE, we selected the right hepatic artery and passed through arteriovenous malformation. Superselective-angiogram showed remnant tumoral staining and remnant tumor was embolized using drug-eluting bead and Adriamycin. Final angiogram showed no remnant tumoral staining and the patient was discharged without complication. We found the rare case of arteriovenous malformation adjacent to HCC, and we performed superselective TACE beyond arteriovenous malformation to treat HCC.
Keywords
Hepatocellular Carcinoma; TACE; Arteriovenous Malformation; Aquired; Superselective;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kollipara R, Odhav A, Rentas KE, Rivard DC, Lowe LH, Dinneen L. Vascular anomalies in pediatric patients: updated classification, imaging, and therapy. Radiol Clin North Am; 51: 659-672, 2013. DOI: https://doi.org/10.1016/j.rcl.2013.04.002   DOI
2 Lowe LH, Marchant TC, Rivard DC, Scherbel AJ. Vascular malformations: classification and terminology the radiologist needs to know. Semin Roentgenol; 47: 106-117, 2012. DOI: https://doi.org/10.1053/j.ro.2011.11.002   DOI
3 Legiehn GM, Heran MK. A Step-by-Step Practical Approach to Imaging Diagnosis and Interventional Radiologic Therapy in Vascular Malformations. Semin Intervent Radiol; 27: 209-231, 2010. DOI: https://doi.org/10.1055/s-0030-1253521   DOI
4 Donnelly LF, Adams DM, Bisset GS 3rd. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic. AJR Am J Roentgenol; 174: 597-608, 2000. DOI: https://doi.org/10.2214/ajr.174.3.1740597   DOI
5 Burrows PE, Mulliken JB, Fellows KE, Strand RD. Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol; 141: 483-488, 1983. DOI: https://doi.org/10.2214/ajr.141.3.483   DOI
6 Alomari A, Dubois J. Interventional management of vascular malformations. Tech Vasc Interv Radiol; 14: 22-31, 2011. DOI: https://doi.org/10.1053/j.tvir.2010.07.006   DOI
7 Guevara CJ, Alomari AI. Interdisciplinary approach to treatment of vascular anomalies. Tech Vasc Interv Radiol; 16: 55-58, 2013. DOI: https://doi.org/10.1053/j.tvir.2013.01.008   DOI
8 Murata S, Mine T, Sugihara F, Yasui D, Yamagu-chi H, Ueda T, Onozawa S, Kumita S. Interven-tional treatment for unresectable hepatocellu-lar carcinoma. World J Gastroenterol; 20: 13453-65, 2014. DOI: https://doi.org/10.3748/wjg.v20.i37.13453   DOI
9 Saraswat VA, Pandey G, Shetty S. Treatment algorithms for managing hepatocellular carci-noma. J Clin Exp Hepatol ; 4 Suppl 3: S80-9, 2014. DOI: https://doi.org/10.1016/j.jceh.2014.05.004   DOI
10 Chen D, Wang R, Meng X, Yan H, Jiang S, Feng R, Zhu K, Xu X, Dou X, Jin L. Prognostic value of serum gamma- glutamyl transferase in unre-sectable hepatocellular carcinoma patients treated with transcatheter arterial chemoem-bolization combined with conformal radiotherapy. Oncol Lett; 8: 2298-304, 2014. DOI: https://doi.org/10.1016/j.jceh.2014.05.004   DOI
11 Ngan H, Peh WC. Arteriovenous Shunting in Hepatocellular Carcinoma: Its Prevalence and Clinical Significance. Clin Radiol ; 52: 36-40, 1997. DOI: https://doi.org/10.1016/S0009-9260(97)80303-0   DOI
12 DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology ; 49: 1729-1764, 2009. DOI: https://doi.org/10.1002/hep.22772   DOI
13 Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet ; 362: 1907-17, 2003. DOI: https://doi.org/10.1016/S0140-6736(03)14964-1   DOI
14 Kumar A, Ahuja CK, Vyas S, Kalra N, Khandel-wal N, Chawla Y, Dhiman RK. Hepatic arterio-venous fistulae: role of interventional radiolo-gy. Dig Dis Sci; 57: 2703-12, 2012. DOI: https://doi.org/10.1007/s10620-012-2331-0   DOI
15 Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg; 69: 412-422, 1982.   DOI